Our analysis indicated that, across various tumor types, RNASET2 expression was associated with a trend for a reduced risk in PCa, even if this association did not reach statistical significance (p ≥ 0.05) (Fig. 1B). This evidence concerns the gene RNASET2 and posterior cortical atrophy.